Hyperbaric Oxygen Therapy for Carbon Monoxide Poisoning
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Hyperbaric Oxygen Therapy for Carbon Monoxide Poisoning?
Hyperbaric oxygen therapy (HBO) helps quickly increase oxygen levels in the body and remove carbon monoxide, which can be crucial for patients who have been unconscious due to poisoning. Some case reports show that patients treated with HBO had no long-term brain damage after recovery, suggesting it may help prevent serious complications.12345
Is hyperbaric oxygen therapy safe for humans?
Hyperbaric oxygen therapy (HBOT) has been widely used and studied for treating carbon monoxide poisoning, and there is a lot of research supporting its use. While the studies focus on its effectiveness, the widespread use and research suggest it is generally considered safe for humans when used appropriately.45678
How does hyperbaric oxygen therapy differ from other treatments for carbon monoxide poisoning?
What is the purpose of this trial?
The optimal treatment strategy with hyperbaric oxygen therapy has been the subject of some debate over the past 3 decades. Initial landmark studies showed a decrease in the incidence of DNS with a single treatment and also with three treatments over the course of 24 hours. These two strategies have continued to be used widely without further evidence comparing them in a direct fashion. Retrospective publications in the years since have been largely conflicting about the benefit of additional hyperbaric treatments. The investigators would seek to randomize patients with carbon monoxide poisoning to receive with 1 or 3 treatments with hyperbaric oxygen and measure their neurologic outcomes.
Research Team
Brian Rowe, MD, MSc, CCFP (EM), FCCP
Principal Investigator
Professor in the Department of Emergency Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, at the University of Alberta
Eligibility Criteria
Adults over 17 years old who have been referred to a Hyperbaric Unit for acute carbon monoxide poisoning are eligible for this trial. Specific details about who cannot participate were not provided.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 1 or 3 hyperbaric oxygen treatments for carbon monoxide poisoning
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on delayed neurologic sequelae
Treatment Details
Interventions
- Hyperbaric Oxygen Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor